Evidence map›Paper›PMID 37671834›Full record

ArticleEMBO reports2023

The obesity-linked human lncRNA AATBC stimulates mitochondrial function in adipocytes.

Maude Giroud, Stefan Kotschi, Yun Kwon, Ophélia Le Thuc, Anne Hoffmann, Manuel Gil-Lozano, Michael Karbiener, Juan Carlos Higareda-Almaraz, Sajjad Khani, Daniel Tews and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Role of lncRNAs in pathophysiology of obesity.Current opinion in physiology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Pulling the trigger: Noncoding RNAs in white adipose tissue browning.Reviews in endocrine & metabolic disorders · 2024
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 5 countries.

Maude Giroud *Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0001-6320-5546
Stefan Kotschi *Institute for Cardiovascular Prevention, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0001-9857-6291
Yun KwonInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
Ophélia Le ThucInstitute for Diabetes and Obesity, Helmholtz Center Munich, Neuherberg, Germany.
Anne HoffmannHelmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0003-3258-3397
Manuel Gil-LozanoInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
Michael KarbienerGlobal Pathogen Safety, Baxter AG, Vienna, Austria.
Juan Carlos Higareda-AlmarazInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
Sajjad KhaniInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
Daniel TewsDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.ORCID 0000-0003-3300-3446
Pamela Fischer-PosovszkyDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Wenfei SunInstitute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.ORCID 0000-0001-5762-6010
Hua DongInstitute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.
Adhideb GhoshInstitute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.ORCID 0000-0002-5160-4571
Christian WolfrumInstitute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.ORCID 0000-0002-3862-6805
Martin WabitschDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Kirsi A VirtanenTurku PET Centre, Turku University Hospital, Turku, Finland.ORCID 0000-0001-6183-4525
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
Søren NielsenThe Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-3119-750X
Anja ZeigererInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0003-4072-0566
Cristina García-CáceresGerman Center for Diabetes Research, Neuherberg, Germany.
Marcel ScheidelerInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0003-4650-7387
Stephan HerzigInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0003-3950-3652
Alexander BarteltInstitute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0001-7840-3991
Heidelberg University · DEHelmholtz Zentrum München · DEETH Zurich · CHUniversität Ulm · DEBaxter (Austria) · ATLudwig-Maximilians-Universität München · DETurku University Hospital · FIUniversity of Copenhagen · DK

Funding

Alexander von Humboldt-Stiftung (AvH)Deutsche Forschungsgemeinschaft (DFG) FI1700/7#x2010;1Deutsche Forschungsgemeinschaft (DFG) SFB1123Deutsche Forschungsgemeinschaft (DFG) TE912/2#x2010;2Deutsche Forschungsgemeinschaft (DFG) TRR205Deutsches Zentrum für Herz-Kreislaufforschung (DZHK)EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC)Helmholtz Zentrum München (Helmholtz Centre Munich, German Research Center for Environmental Health)
6 · The paper itself

Abstract

Adipocytes are critical regulators of metabolism and energy balance. While white adipocyte dysfunction is a hallmark of obesity-associated disorders, thermogenic adipocytes are linked to cardiometabolic health. As adipocytes dynamically adapt to environmental cues by functionally switching between white and thermogenic phenotypes, a molecular understanding of this plasticity could help improving metabolism. Here, we show that the lncRNA Apoptosis associated transcript in bladder cancer (AATBC) is a human-specific regulator of adipocyte plasticity. Comparing transcriptional profiles of human adipose tissues and cultured adipocytes we discovered that AATBC was enriched in thermogenic conditions. Using primary and immortalized human adipocytes we found that AATBC enhanced the thermogenic phenotype, which was linked to increased respiration and a more fragmented mitochondrial network. Expression of AATBC in adipose tissue of mice led to lower plasma leptin levels. Interestingly, this association was also present in human subjects, as AATBC in adipose tissue was inversely correlated with plasma leptin levels, BMI, and other measures of metabolic health. In conclusion, AATBC is a novel obesity-linked regulator of adipocyte plasticity and mitochondrial function in humans.

Indexed as

AdipocytesMitochondriaObesityRNA, Long NoncodingAdipose TissueAnimalsFemaleHumansLeptinMaleMiceThermogenesisLeptinRNA, Long Noncodingadipocytemitochondrial dynamicsnon-coding RNAobesitythermogenesis

Identifiers

PMID37671834
PMCPMC10561178
OpenAlexW4386467605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.